Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
3.700
-0.230 (-5.85%)
At close: Sep 17, 2025, 4:00 PM EDT
3.780
+0.080 (2.16%)
After-hours: Sep 17, 2025, 7:59 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $20.74 million as of September 17, 2025. Its market cap has increased by 20.61% in one year.
Market Cap
20.74M
Enterprise Value
18.20M
1-Year Change
20.61%
Ranking
Category
Stock Price
$3.70
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $20.74M, a decrease of -67.73%. That is a compound annual growth rate of -25.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 20.74M | 27.42% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |